IL96549A - Production of biologically active transforming growth factor type B-like protein or salts thereof - Google Patents

Production of biologically active transforming growth factor type B-like protein or salts thereof

Info

Publication number: IL96549A
Authority: IL; Israel
Prior art keywords: production; biologically active; protein; salts; growth factor
Prior art date: 1989-12-06

Application number

IL9654990A

Other languages

English (en)

Other versions

IL96549A0 (en

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-06

Filing date

1990-12-05

Publication date

2000-10-31

1990-12-05 Application filed by Novartis Ag filed Critical Novartis Ag

1991-09-16 Publication of IL96549A0 publication Critical patent/IL96549A0/xx

2000-10-31 Publication of IL96549A publication Critical patent/IL96549A/xx

Links

102000009618 Transforming Growth Factors Human genes 0.000 title 1
108010009583 Transforming Growth Factors Proteins 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 abstract 3
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Analytical Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Crystallography & Structural Chemistry (AREA)
Wood Science & Technology (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Biotechnology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Rheumatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

IL9654990A 1989-12-06 1990-12-05 Production of biologically active transforming growth factor type B-like protein or salts thereof IL96549A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898927546A GB8927546D0 (en)	1989-12-06	1989-12-06	Process for the production of biologically active tgf-beta

Publications (2)

Publication Number	Publication Date
IL96549A0 IL96549A0 (en)	1991-09-16
IL96549A true IL96549A (en)	2000-10-31

Family

ID=10667491

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9654990A IL96549A (en)	1989-12-06	1990-12-05	Production of biologically active transforming growth factor type B-like protein or salts thereof

Country Status (23)

Country	Link
US (2)	US5650494A (de)
EP (2)	EP0891985A1 (de)
JP (1)	JP3048061B2 (de)
KR (1)	KR100203230B1 (de)
AT (1)	ATE178616T1 (de)
AU (1)	AU638075B2 (de)
CA (1)	CA2031430C (de)
DE (1)	DE69033040T2 (de)
DK (1)	DK0433225T3 (de)
ES (1)	ES2132066T3 (de)
FI (1)	FI103278B1 (de)
GB (1)	GB8927546D0 (de)
GR (1)	GR3030703T3 (de)
HU (1)	HU218144B (de)
IE (2)	IE990992A1 (de)
IL (1)	IL96549A (de)
MX (1)	MX172600B (de)
NO (1)	NO301768B1 (de)
NZ (1)	NZ236333A (de)
PH (1)	PH31649A (de)
PT (1)	PT96068B (de)
SG (1)	SG52690A1 (de)
ZA (1)	ZA909762B (de)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6150328A (en)	1986-07-01	2000-11-21	Genetics Institute, Inc.	BMP products
GB8927546D0 (en) *	1989-12-06	1990-02-07	Ciba Geigy	Process for the production of biologically active tgf-beta
AU664021B2 (en) *	1990-09-05	1995-11-02	Natinco Nv	Solubilization of proteins in active forms
GB9106678D0 (en) *	1991-03-28	1991-05-15	Ferguson Mark W J	Wound healing
WO1993009229A1 (en)	1991-11-04	1993-05-13	Genetics Institute, Inc.	Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
US20080139474A1 (en) *	1991-11-04	2008-06-12	David Israel	Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
AU2738392A (en) *	1991-11-11	1993-05-13	Ciba-Geigy Ag	Novel hybrid transforming growth factors
US5288931A (en) *	1991-12-06	1994-02-22	Genentech, Inc.	Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
DK0625989T3 (da) *	1992-02-12	2000-06-26	Bioph Biotech Entw Pharm Gmbh	DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
GB9206861D0 (en)	1992-03-28	1992-05-13	Univ Manchester	Wound healing and treatment of fibrotic disorders
US6884787B2 (en) *	2001-07-14	2005-04-26	Isis Pharmaceuticals, Inc.	Antisense modulation of transforming growth factor-beta 3 expression
DE4243729A1 (de) *	1992-12-23	1994-06-30	Behringwerke Ag	Verfahren zur Reaktivierung von gereinigten Membranproteinen
CA2151597A1 (en) *	1993-01-08	1994-07-21	Robert L. Garlick	Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein
US6455689B1 (en) *	1993-04-30	2002-09-24	Biognostik Gesellschaft für Biomolekulare Diagnostik mbH	Antisense-oligonucleotides for transforming growth factor-β (TGF-β)
US5663304A (en) *	1993-08-20	1997-09-02	Genentech, Inc.	Refolding of misfolded insulin-like growth factor-I
US6291206B1 (en)	1993-09-17	2001-09-18	Genetics Institute, Inc.	BMP receptor proteins
CA2149657A1 (en) *	1993-09-29	1995-04-06	Billie M. York	Compositions containing growth factors and antiplastic agents
US5411940A (en) *	1993-09-29	1995-05-02	Alcon Laboratories, Inc.	Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma
AU689184B2 (en)	1993-12-07	1998-03-26	Genetics Institute, Llc	BMP-12, BMP-13 and tendon-inducing compositions thereof
US5399677A (en) *	1993-12-07	1995-03-21	Genetics Institute, Inc.	Mutants of bone morphogenetic proteins
US6027919A (en)	1993-12-07	2000-02-22	Genetics Institute, Inc.	BMP-12 and BMP-13 proteins and DNA encoding them
TW517059B (en) *	1994-07-25	2003-01-11	Ciba Geigy Ag	New process for the production of biologically active protein
TW440566B (en) *	1994-07-25	2001-06-16	Novartis Ag	Novel process for the production of biologically active dimeric protein
AU3109795A (en) *	1994-07-25	1996-02-22	Novartis Ag	Process for folding of proteins like recombinant hirudin or epidermal growth factor
WO1996033215A1 (en) *	1995-04-19	1996-10-24	Hoechst Pharmaceuticals & Chemicals K.K.	Novel protein and process for producing the same
US5714371A (en) *	1995-05-12	1998-02-03	Schering Corporation	Method for refolding insoluble aggregates of hepatitis C virus protease
US5800811A (en) *	1995-06-06	1998-09-01	Hall; Frederick L.	Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site
US6352972B1 (en) *	1995-06-06	2002-03-05	Marcel E. Nimni	Bone morphogenetic proteins and their use in bone growth
US6040431A (en) *	1995-06-07	2000-03-21	Stryker Corporation	Single chain analogs of the TGF-β superfamily (morphons)
WO1997016556A1 (en)	1995-10-30	1997-05-09	Massachusetts Institute Of Technology	Rationally designed polysaccharide lyases derived from heparinase i
DE69636739T2 (de) *	1995-12-21	2007-10-18	Ajinomoto Co., Inc.	Verfahren zur rückfaltung von menschlichem activin a
US20030185792A1 (en) *	1996-01-22	2003-10-02	Curis, Inc.	Morphogen analogs of bone morphogenic proteins
WO1997026277A2 (en) *	1996-01-22	1997-07-24	Creative Biomolecules, Inc.	Morphogen analogs and methods for producing them
US6664227B1 (en)	1996-03-01	2003-12-16	Genetics Institute, Llc	Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
US7811793B2 (en)	1996-12-25	2010-10-12	Biopharma Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh	Process for preparing purified active monomer of bone-derived factor
US6500920B1 (en) *	1997-06-19	2002-12-31	St. Louis University	Inhibitor of transforming growth factor β and A method of inhibiting the biological effects of transforming growth factor
US7723473B2 (en)	1997-06-19	2010-05-25	St. Louis University	Peptide antagonists of TGF-beta family members and therapeutic uses thereof
EP0896825B1 (de)	1997-08-14	2002-07-17	Sulzer Innotec Ag	Zusammensetzung und Vorrichtung zur Reparatur von Knorpelgewebe in vivo bestehend aus Nanokapseln mit osteoinduktiven und/oder chondroinduktiven Faktoren
US20020052026A1 (en)	1997-10-08	2002-05-02	Steven M. Vicik	Methods of refolding proteins
DE19749259A1 (de) *	1997-11-07	1999-05-12	Dade Behring Marburg Gmbh	Verfahren zur Herstellung von funktionalem rekombinantem Gewebsfaktor
CZ298364B6 (cs) *	1998-02-05	2007-09-05	Smithkline Beecham Biologicals S. A.	Deriváty antigenu asociovaných s nádory z MAGE rodiny a sekvence nukleových kyselin kodující tyto deriváty, jejich použití pro prípravu fúzních proteinu a prostredku pro vakcinaci
US6057128A (en)	1998-03-17	2000-05-02	Genetics Institute, Inc.	MU-1, member of the cytokine receptor family
FR2776521B1 (fr) *	1998-03-27	2000-12-15	Pf Medicament	Utilisation de conjugues p40 actifs par voie nasale
EP1109919A2 (de)	1998-08-27	2001-06-27	Massachusetts Institute Of Technology	Von heparinase i und ii abgeleitete heparinasen
US7056504B1 (en)	1998-08-27	2006-06-06	Massachusetts Institute Of Technology	Rationally designed heparinases derived from heparinase I and II
US6933272B1 (en)	1998-09-22	2005-08-23	Erik Helmerhorst	Use of non-peptidyl compounds for the treatment of insulin related ailments
CA2345024C (en) *	1998-10-07	2009-05-19	Stryker Corporation	Modified tgf-.beta. superfamily proteins
US6677432B1 (en)	1998-10-07	2004-01-13	Stryker Corporation	Mutations of the C-terminal portion of TGF-β superfamily proteins
US6846906B1 (en)	1998-10-07	2005-01-25	Stryker Corporation	Modified proteins of the TGF-β superfamily, including morphogenic proteins
US6992066B2 (en)	1998-10-16	2006-01-31	Zimmer Orthobiologics, Inc.	Povidone-containing carriers for polypeptide growth factors
US7087577B2 (en)	1998-10-16	2006-08-08	Zimmer Orthobiologies, Inc.	Method of promoting natural bypass
ES2146552B1 (es) *	1998-11-24	2001-04-16	Inst Cientifico Tecnol Navarra	Peptidos inhibidores de tgf/31
CA2358609A1 (en) *	1999-01-07	2000-07-13	Takeda Chemical Industries, Ltd.	Process for producing activated protein
US6727224B1 (en)	1999-02-01	2004-04-27	Genetics Institute, Llc.	Methods and compositions for healing and repair of articular cartilage
DE19906096A1 (de)	1999-02-13	2000-08-17	Walter Sebald	Protein mit einem Heparin-bindenden Epitop
US7412332B1 (en)	1999-04-23	2008-08-12	Massachusetts Institute Of Technology	Method for analyzing polysaccharides
DE19944626A1 (de) *	1999-09-17	2001-03-22	Knoell Hans Forschung Ev	Verfahren zur Herstellung von dimeren, biologisch aktiven knochenmorphogenetischen Proteinen
DK1223990T3 (da)	1999-10-15	2004-11-29	Inst Genetics Llc	Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
WO2001066772A2 (en)	2000-03-08	2001-09-13	Massachusetts Institute Of Technology	Heparinase iii and uses thereof
DE10026713A1 (de) *	2000-05-30	2001-12-06	Walter Sebald	Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
US7081240B1 (en) *	2000-06-28	2006-07-25	Zimmer Orthobiologics, Inc.	Protein mixtures for wound healing
ATE426805T1 (de)	2000-09-12	2009-04-15	Massachusetts Inst Technology	Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
AU2440802A (en)	2000-10-18	2002-04-29	Massachusetts Inst Technology	Methods and products related to pulmonary delivery of polysaccharides
US7442370B2 (en)	2001-02-01	2008-10-28	Biogen Idec Ma Inc.	Polymer conjugates of mutated neublastin
IL157446A0 (en)	2001-02-23	2004-03-28	Immunex Corp Immunex Corp	Increased recovery of active proteins
US7276580B2 (en)	2001-03-12	2007-10-02	Biogen Idec Ma Inc.	Neurotrophic factors
US7226587B2 (en)	2001-06-01	2007-06-05	Wyeth	Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en)	2001-06-08	2006-12-01	Wyeth Corp	Calcium phosphate delivery vehicles for osteoinductive proteins
FI117667B (fi)	2001-07-05	2007-01-15	Univ Zuerich	Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä
ES2629395T3 (es)	2001-10-04	2017-08-09	Genetics Institute, Llc	Métodos y composiciones para modular la actividad de la interleucina-21
US7232802B2 (en)	2001-12-21	2007-06-19	Zimmer Orthobiologics, Inc.	Compositions and methods for promoting myocardial and peripheral angiogenesis
WO2003066676A1 (en) *	2002-02-05	2003-08-14	Geymonat S.P.A.	Production process of recombinant placental growth factor
RU2295535C2 (ru) *	2002-02-05	2007-03-20	Джимонат С.П.А.	Рекомбинантный плацентарный фактор роста и способ его получения
US7622562B2 (en)	2002-06-26	2009-11-24	Zimmer Orthobiologics, Inc.	Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7241740B2 (en)	2002-08-13	2007-07-10	Wyeth	Peptides as solubilizing excipients for transforming growth factor beta proteins
JP4571776B2 (ja) *	2002-11-05	2010-10-27	Ｊｘ日鉱日石エネルギー株式会社	潤滑油組成物
US7074412B2 (en)	2003-01-30	2006-07-11	The University Of Zurich	Pharmaceutical composition
WO2004094592A2 (en)	2003-04-18	2004-11-04	Biogen Idec Ma Inc.	Polymer-conjugated glycosylated neublastin
JP5392981B2 (ja)	2003-09-12	2014-01-22	ワイス・エルエルシー	骨形成蛋白の送達のための注入可能なリン酸カルシウム固体ロッドおよびペースト
ES2396689T3 (es)	2003-12-11	2013-02-25	Isto Technologies Inc.	Sistema de cartílago particulado
CA2577690C (en) *	2004-08-19	2013-08-06	Biogen Idec Ma Inc.	Refolding transforming growth factor beta family proteins
DK1786454T3 (da) *	2004-08-19	2010-09-06	Biogen Idec Inc	Neublastinvarianter
WO2006081379A1 (en) *	2005-01-26	2006-08-03	Wyeth	Use of sfrps as markers of bmp activity
CN101160528A (zh)	2005-02-14	2008-04-09	惠氏公司	Il17-f在诊断和治疗气道炎症中的用途
GT200600065A (es)	2005-02-14	2006-10-02		Anticuerpos para interleucina-17f y otros antagonistas de la señalizacion de il-17f y sus usos
EP1863518A2 (de) *	2005-03-30	2007-12-12	Wyeth	VERFAHREN ZUR STIMULATION DES WAARWACHSTUMS MITTELS VERABREICHUNG VON BMPs
GT200600148A (es)	2005-04-14	2006-11-22		Metodos para el tratamiento y la prevencion de fibrosis
GB0514262D0 (en) *	2005-07-12	2005-08-17	Renovo Ltd	Promotion of epithelial regeneration
WO2007014170A2 (en) *	2005-07-25	2007-02-01	Trubion Pharmaceuticals, Inc.	Compositions and methods for protein deaggregation
GB0516204D0 (en) *	2005-08-06	2005-09-14	Riotech Pharmaceuticals Ltd	Methods
EP1916964A4 (de)	2005-08-26	2015-11-04	Zimmer Inc	Implantate und verfahren zur behebung, ersetzung und behandlung von gelenkkrankheiten
TWI501774B (zh)	2006-02-27	2015-10-01	Biogen Idec Inc	神經性病症之治療
US7582609B2 (en) *	2006-03-01	2009-09-01	Digna Biotech, S.L.	Method for the treatment of skin fibrosis and suitable compositions for such treatment
ES2450065T3 (es) *	2006-03-01	2014-03-21	Biogen Idec Ma Inc.	Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF
GB0604966D0 (en) *	2006-03-11	2006-04-19	Renovo Ltd	Medicaments and proteins
GB0604938D0 (en)	2006-03-11	2006-04-19	Renovo Ltd	Proteins, nucleic acids and medicaments
GB0604964D0 (en) *	2006-03-11	2006-04-19	Renovo Ltd	Protein folding
AR062069A1 (es) *	2006-07-14	2008-10-15	Genentech Inc	Replegado de proteinas recombinantes
GB0617816D0 (en) *	2006-09-11	2006-10-18	Renovo Ltd	Nucleic acids and methods of protein expression
SI2078071T1 (sl)	2006-11-08	2015-05-29	Wyeth Llc	Racionalno zasnovana gojišča za celično kulturo
US8163549B2 (en)	2006-12-20	2012-04-24	Zimmer Orthobiologics, Inc.	Method of obtaining viable small tissue particles and use for tissue repair
AU2008240191B2 (en)	2007-04-12	2013-09-19	Zimmer, Inc.	Compositions and methods for tissue repair
TW200902708A (en)	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
EP2142205B1 (de)	2007-05-01	2014-04-02	Biogen Idec MA Inc.	Neublastin Peptide für erhöhte Vaskularisierung im Gewebe mit reduzierter Durchblutung
WO2009020964A2 (en) *	2007-08-08	2009-02-12	Biogen Idec Ma Inc.	Anti-neublastin antibodies and uses thereof
ES2657055T3 (es)	2007-08-09	2018-03-01	Wyeth Llc	Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
US8946201B2 (en)	2007-08-27	2015-02-03	Saint Louis University	Methods for inhibiting TGF-β
CN102159219B (zh)	2008-09-16	2015-06-24	圣路易斯大学	提高转化生长因子-β信号发送的方法
US8494140B2 (en) *	2008-10-30	2013-07-23	Centurylink Intellectual Property Llc	System and method for voice activated provisioning of telecommunication services
US8058407B2 (en)	2008-10-31	2011-11-15	Wyeth Llc	Purification of acidic proteins using ceramic hydroxyapatite chromatography
EP3366692A1 (de)	2009-06-22	2018-08-29	Amgen, Inc	Proteinneufaltung mit einem chemisch gesteuerten redoxzustand
AU2010266093B2 (en)	2009-06-25	2013-06-27	Amgen Inc.	Capture purification processes for proteins expressed in a non-mammalian system
KR100991203B1 (ko) *	2010-05-10	2010-11-01	심영복	골형성 단백질의 정제 방법
WO2012029148A1 (ja)	2010-09-01	2012-03-08	株式会社オステオファーマ	組換えヒト骨形成タンパク質－２凍結乾燥製剤
KR20180128097A (ko) *	2012-02-10	2018-11-30	재패닉 코포레이션	비 인간 줄기세포의 배양 상등액을 원료로 하는 화장품 또는 피부 재생 촉진제, 및 단백질의 이온 도입 방법
US10188732B2 (en)	2012-08-06	2019-01-29	Biogen Ma Inc.	Methods and compositions for inactivating enveloped viruses
US20140178343A1 (en)	2012-12-21	2014-06-26	Jian Q. Yao	Supports and methods for promoting integration of cartilage tissue explants
US9758786B2 (en)	2016-02-09	2017-09-12	Autotelic, Llc	Compositions and methods for treating pancreatic cancer
NZ746109A (en)	2016-12-30	2022-12-23	Biogend Therapeutics Co Ltd	Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof
KR20240064367A (ko) *	2022-11-04	2024-05-13	주식회사 대웅제약	TGF-β3 단백질의 정제방법

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA811970B (en) *	1980-03-27	1982-11-24	Lilly Co Eli	Process for producing an insulin
GR79124B (de) *	1982-12-22	1984-10-02	Genentech Inc
US4620948A (en) *	1982-12-22	1986-11-04	Genentech, Inc.	Purification and activity assurance of precipitated heterologous proteins
WO1984004924A1 (en) *	1983-06-03	1984-12-20	Us Commerce	Purified transforming growth factor-beta derived from human platelets and placentas
DE3587022T2 (de) *	1984-02-17	1993-06-17	Genentech Inc	Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
US4572798A (en) *	1984-12-06	1986-02-25	Cetus Corporation	Method for promoting disulfide bond formation in recombinant proteins
US4731440A (en) *	1985-02-22	1988-03-15	Monsanto Company	Method of somatotropin solubilization using dimethylsulfone and naturation
IL78197A (en) *	1985-03-22	1991-07-18	Genentech Inc	Nucleic acid encoding tgf-beta and its uses
GB8508340D0 (en) *	1985-03-29	1985-05-09	Creighton T E	Production of protein
EP0208539A3 (de) *	1985-07-11	1988-08-03	Repligen Corporation	In Falten gelegte Proteine, durch Disulfid gebunden
US5453363A (en) *	1985-10-23	1995-09-26	Boehringer Mannheim Gmbh	Process for the activation of t-PA or Ing after genetic expression in prokaryotes
NZ222168A (en) *	1986-10-20	1991-05-28	Oncogene Science Inc	Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
PT86144B (pt) *	1986-11-17	1990-08-31	Sandoz Sa	Processo para a preparacao de uma proteina tendo actividade semelhante a factor g-tsf humano e de composicoes farmaceuticas que o contem
FI100106B (fi) *	1986-12-05	1997-09-30	Novartis Ag	Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
US4931548A (en) *	1987-01-30	1990-06-05	Techne Corporation	Heterodimer form of transforming growth factor-beta
US5013653A (en) *	1987-03-20	1991-05-07	Creative Biomolecules, Inc.	Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
IL86090A (en) *	1987-04-16	1993-03-15	Cetus Oncology Corp	Production of purified, biologically active, bacterially produced recombinant human csf-1
US5162507A (en) *	1987-05-11	1992-11-10	Cetus Corporation	Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
ATE156491T1 (de) *	1987-05-11	1997-08-15	Chiron Corp	Prozess zur gewinnung von gereinigtem, oxidiertem, renaturiertem, rekombinantem interleukin-2 aus mikroorganismen
EP0293785A3 (de) *	1987-05-29	1990-05-02	Oncogen Limited Partnership	Klonierung und Expression von transformierendem Affenwachstumsfaktor-SS 1
US4985544A (en) *	1987-08-04	1991-01-15	Kyowa Hakko Kogyo Co., Ltd.	Process for renaturing fish growth hormone
US5061786A (en) *	1989-05-25	1991-10-29	Genentech, Inc.	Biologically active polypeptides based on transforming growth factor-β
GB8927546D0 (en) *	1989-12-06	1990-02-07	Ciba Geigy	Process for the production of biologically active tgf-beta
US5144006A (en) *	1991-06-13	1992-09-01	The Rockefeller University	Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
AU2738392A (en) *	1991-11-11	1993-05-13	Ciba-Geigy Ag	Novel hybrid transforming growth factors

1989
- 1989-12-06 GB GB898927546A patent/GB8927546D0/en active Pending
1990
- 1990-11-27 DE DE69033040T patent/DE69033040T2/de not_active Expired - Lifetime
- 1990-11-27 ES ES90810922T patent/ES2132066T3/es not_active Expired - Lifetime
- 1990-11-27 SG SG1996007909A patent/SG52690A1/en unknown
- 1990-11-27 AU AU67018/90A patent/AU638075B2/en not_active Expired
- 1990-11-27 DK DK90810922T patent/DK0433225T3/da active
- 1990-11-27 EP EP98113487A patent/EP0891985A1/de not_active Withdrawn
- 1990-11-27 AT AT90810922T patent/ATE178616T1/de not_active IP Right Cessation
- 1990-11-27 EP EP90810922A patent/EP0433225B1/de not_active Expired - Lifetime
- 1990-11-30 JP JP2330871A patent/JP3048061B2/ja not_active Expired - Lifetime
- 1990-12-03 FI FI905956A patent/FI103278B1/fi active IP Right Grant
- 1990-12-04 MX MX023579A patent/MX172600B/es unknown
- 1990-12-04 PT PT96068A patent/PT96068B/pt not_active IP Right Cessation
- 1990-12-04 CA CA002031430A patent/CA2031430C/en not_active Expired - Lifetime
- 1990-12-04 NZ NZ236333A patent/NZ236333A/en unknown
- 1990-12-05 HU HU084/90A patent/HU218144B/hu unknown
- 1990-12-05 KR KR1019900019881A patent/KR100203230B1/ko not_active Expired - Lifetime
- 1990-12-05 IL IL9654990A patent/IL96549A/xx not_active IP Right Cessation
- 1990-12-05 IE IE19990992A patent/IE990992A1/en not_active IP Right Cessation
- 1990-12-05 NO NO905264A patent/NO301768B1/no not_active IP Right Cessation
- 1990-12-05 ZA ZA909762A patent/ZA909762B/xx unknown
- 1990-12-05 IE IE438690A patent/IE904386A1/en not_active IP Right Cessation
1994
- 1994-03-25 PH PH8001A patent/PH31649A/en unknown
1995
- 1995-06-07 US US08/486,057 patent/US5650494A/en not_active Expired - Lifetime
1997
- 1997-01-24 US US08/789,588 patent/US5922846A/en not_active Expired - Fee Related
1999
- 1999-07-07 GR GR990401786T patent/GR3030703T3/el unknown

Also Published As

Publication number	Publication date
FI905956L (fi)	1991-06-07
SG52690A1 (en)	1998-09-28
DK0433225T3 (da)	1999-10-25
HU218144B (hu)	2000-06-28
IE990992A1 (en)	2000-12-13
IE904386A1 (en)	1991-06-19
NO905264D0 (no)	1990-12-05
EP0433225B1 (de)	1999-04-07
HU908084D0 (en)	1991-06-28
DE69033040D1 (de)	1999-05-12
GB8927546D0 (en)	1990-02-07
US5650494A (en)	1997-07-22
DE69033040T2 (de)	1999-09-09
NO301768B1 (no)	1997-12-08
CA2031430C (en)	2003-05-27
GR3030703T3 (en)	1999-11-30
FI103278B (fi)	1999-05-31
CA2031430A1 (en)	1991-06-07
EP0433225A1 (de)	1991-06-19
MX172600B (es)	1994-01-03
AU638075B2 (en)	1993-06-17
AU6701890A (en)	1991-06-13
NO905264L (no)	1991-06-07
PT96068B (pt)	1998-02-27
FI103278B1 (fi)	1999-05-31
IL96549A0 (en)	1991-09-16
NZ236333A (en)	1992-03-26
ES2132066T3 (es)	1999-08-16
EP0891985A1 (de)	1999-01-20
KR910012240A (ko)	1991-08-07
JP3048061B2 (ja)	2000-06-05
US5922846A (en)	1999-07-13
ATE178616T1 (de)	1999-04-15
PH31649A (en)	1999-01-12
HUT56880A (en)	1991-10-28
KR100203230B1 (ko)	1999-06-15
JPH03191791A (ja)	1991-08-21
PT96068A (pt)	1991-09-30
FI905956A0 (fi)	1990-12-03
ZA909762B (en)	1991-08-28

Legal Events

Date	Code	Title
2001-03-19	FF	Patent granted
2001-06-14	KB	Patent renewed
2005-02-20	KB	Patent renewed
2009-06-15	KB	Patent renewed
2011-07-31	EXP	Patent expired

Publication	Publication Date	Title
IL96549A (en)	2000-10-31	Production of biologically active transforming growth factor type B-like protein or salts thereof
DE68923819D1 (de)	1995-09-21	Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE59005250D1 (de)	1994-05-11	Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen.
DE69230112D1 (de)	1999-11-11	Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE59000270D1 (de)	1992-10-01	Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
DE3650358D1 (de)	1995-09-07	Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
ATE76753T1 (de)	1992-06-15	Pharmazeutische zusammensetzung zur intranasalen verabreichung, die ghrh, einen cholinergischen agonisten und gegebenenfalls ein gallensalz enthaelt.
ATE79254T1 (de)	1992-08-15	Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
HUT50195A (en)	1989-12-28	New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
FR2635527B1 (fr)	1992-06-12	Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament
IL91152A0 (en)	1990-03-19	Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ATE85893T1 (de)	1993-03-15	Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
ATE145939T1 (de)	1996-12-15	Mitogen für die glatte muskulatur und dessen kodierende dns
IL85031A (en)	1992-07-15	Lyophilized aspoxicillin preparation and its manufacture
RU93034376A (ru)	1997-01-27	Лекарственное средство, стимулирующее эритроидный и гранулоцитарный ростки кроветворения при цитостатических миелодепрессиях
ATE79750T1 (de)	1992-09-15	Pharmazeutische zusammensetzung mit antikrebswirkung und methode fuer die behandlung von krebs.
EP0304897A3 (de)	1990-02-07	Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen
MX9800686A (es)	1998-10-31	Nueva proteina hmw humana mp52s.